Overview

Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet

Status:
Completed
Trial end date:
2019-07-17
Target enrollment:
Participant gender:
Summary
To Evaluate the Efficacy and Safety of CKD-333
Phase:
Phase 3
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical